385 related articles for article (PubMed ID: 27874250)
1. Immunosuppression in pediatric liver transplant recipients: Unique aspects.
Miloh T; Barton A; Wheeler J; Pham Y; Hewitt W; Keegan T; Sanchez C; Bulut P; Goss J
Liver Transpl; 2017 Feb; 23(2):244-256. PubMed ID: 27874250
[TBL] [Abstract][Full Text] [Related]
2. Tolerance after liver transplantation: Where are we?
Feng S; Bucuvalas J
Liver Transpl; 2017 Dec; 23(12):1601-1614. PubMed ID: 28834221
[TBL] [Abstract][Full Text] [Related]
3. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
Charlton M; Levitsky J; Aqel B; OʼGrady J; Hemibach J; Rinella M; Fung J; Ghabril M; Thomason R; Burra P; Little EC; Berenguer M; Shaked A; Trotter J; Roberts J; Rodriguez-Davalos M; Rela M; Pomfret E; Heyrend C; Gallegos-Orozco J; Saliba F
Transplantation; 2018 May; 102(5):727-743. PubMed ID: 29485508
[TBL] [Abstract][Full Text] [Related]
4. A novel immune function biomarker identifies patients at risk of clinical events early following liver transplantation.
Sood S; Haifer C; Yu L; Pavlovic J; Churilov L; Gow PJ; Jones RM; Angus PW; Visvanathan K; Testro AG
Liver Transpl; 2017 Apr; 23(4):487-497. PubMed ID: 28133934
[TBL] [Abstract][Full Text] [Related]
5. Living donor liver transplantation during the first 3 months of life.
Kasahara M; Sakamoto S; Sasaki K; Uchida H; Kitajima T; Shigeta T; Narumoto S; Hirata Y; Fukuda A
Liver Transpl; 2017 Aug; 23(8):1051-1057. PubMed ID: 28220684
[TBL] [Abstract][Full Text] [Related]
6. Towards minimizing immunosuppression in pediatric liver transplant recipients.
Turmelle YP; Nadler ML; Anderson CD; Doyle MB; Lowell JA; Shepherd RW
Pediatr Transplant; 2009 Aug; 13(5):553-9. PubMed ID: 19067920
[TBL] [Abstract][Full Text] [Related]
7. Longterm outcome of the liver graft: The pathologist's perspective.
Demetris AJ
Liver Transpl; 2017 Oct; 23(S1):S70-S75. PubMed ID: 28834080
[No Abstract] [Full Text] [Related]
8.
Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
[TBL] [Abstract][Full Text] [Related]
9. Current Practice in Immunosuppression in Pediatric Liver Transplantation.
Vincenzi R; Fonseca EA; Roda KMO; Chapchap P; Neto JS
Curr Pharm Des; 2020; 26(28):3402-3405. PubMed ID: 32534559
[TBL] [Abstract][Full Text] [Related]
10. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
11. Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients.
Lieber SR; Helcer J; Leven E; Knight CS; Wlodarkiewicz C; Shenoy A; Shemesh E; Florman SS; Schiano TD; Annunziato RA
Exp Clin Transplant; 2018 Oct; 16(5):533-540. PubMed ID: 28969524
[TBL] [Abstract][Full Text] [Related]
12. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Charlton M; Seaberg E
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
[TBL] [Abstract][Full Text] [Related]
13. Trajectory of adherence behavior in pediatric and adolescent liver transplant recipients: The medication adherence in children who had a liver transplant cohort.
Shemesh E; Duncan S; Anand R; Shneider BL; Alonso EM; Mazariegos GV; Venick RS; Annunziato RA; Bucuvalas JC
Liver Transpl; 2018 Jan; 24(1):80-88. PubMed ID: 28779546
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
[TBL] [Abstract][Full Text] [Related]
15. Adherence in liver transplant recipients.
Burra P; Germani G; Gnoato F; Lazzaro S; Russo FP; Cillo U; Senzolo M
Liver Transpl; 2011 Jul; 17(7):760-70. PubMed ID: 21384527
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation.
Liberal R; Vergani D; Mieli-Vergani G
Liver Transpl; 2016 Sep; 22(9):1275-83. PubMed ID: 27257963
[TBL] [Abstract][Full Text] [Related]
17. Unusual Indications for a Liver Transplant: A Single-Center Experience.
Akdur A; Kirnap M; Ayvazoglu Soy EH; Ozcay F; Moray G; Arslan G; Haberal M
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):128-132. PubMed ID: 28260452
[TBL] [Abstract][Full Text] [Related]
18. Impact of donor-recipient genetic relationship on outcome of living donor liver transplantation.
Ali MA; Elshobari MM; Salah T; Kandeel AR; Sultan AM; Elghawalby AN; Shehta A; Elsayed U; Fathy O; Yassen A; Wahab MA
Liver Transpl; 2017 Jan; 23(1):43-49. PubMed ID: 27516392
[TBL] [Abstract][Full Text] [Related]
19. Longterm renal allograft survival after sequential liver-kidney transplantation from a single living donor.
Kitajima K; Ogawa Y; Miki K; Kai K; Sannomiya A; Iwadoh K; Murakami T; Koyama I; Nakajima I; Fuchinoue S
Liver Transpl; 2017 Mar; 23(3):315-323. PubMed ID: 27862900
[TBL] [Abstract][Full Text] [Related]
20. Liver allograft pathology in healthy pediatric liver transplant recipients.
Briem-Richter A; Ganschow R; Sornsakrin M; Brinkert F; Schirmer J; Schaefer H; Grabhorn E
Pediatr Transplant; 2013 Sep; 17(6):543-9. PubMed ID: 23834615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
